| 2026 |
Widagdo, I., Bui, T., Cortis, L., Andrade, A., & Roughead, E. (2026). Concurrent use of medicines with similar adverse drug reaction profiles in older adults: identifying potential deprescribing opportunities using population-level dispensing data.. International journal of clinical pharmacy.
DOI |
| 2025 |
Ayeno, H. D., Atee, M., Kassie, G. M., Suppiah, V., Widagdo, I., & Nguyen, T. A. (2025). Psychotropic medications versus non-pharmacologic approaches for managing behavioural and psychological symptoms in Australian aged care residents with dementia: general practitioners’ and physicians’ perspectives. Therapeutic Advances in Psychopharmacology, 15(20451253251387908), 15 pages.
DOI Scopus1 WoS1 Europe PMC1 |
| 2025 |
Amer, H., Marotti, S., Widagdo, I., Goldsworthy, S., Johnson, J., & Kalisch Ellett, L. (2025). Collaborative pharmacist prescribing models in Australian hospitals: a scoping study. Research in Social and Administrative Pharmacy, 22(2), 1-10.
DOI |
| 2025 |
Widagdo, I., Kemp-Casey, A., Dorj, G., Andrade, A., & Pratt, N. (2025). Denominator Matters: Comparing the Impact of Estimated Resident Population Versus Medicare Enrolment Population on Healthcare Utilisation Analyses. Health Promotion Journal of Australia, 36(3), e70069.
DOI Scopus1 WoS1 Europe PMC1 |
| 2025 |
Amer, H., Marotti, S., Inglis, J. M., Widagdo, I., Goldsworthy, S., Johnson, J., & Kalisch Ellett, L. (2025). Evaluating medication discrepancies and harm: a matched cohort study of collaborative pharmacist prescribing in a statewide healthcare system using electronic prescribing. International Journal of Clinical Pharmacy, online(1), 1-10.
DOI Scopus1 WoS1 Europe PMC1 |
| 2025 |
Widagdo, I., Kerr, M., Ellett, L. K., Schlegel, C., Sadeqzadeh, E., Wang, A., . . . Pratt, N. (2025). Validity of the Updated Rx-Risk Index as a Disease Identification and Risk-Adjustment Tool for Use in Observational Health Studies. Clinical Interventions in Aging, 20, 309-323.
DOI |
| 2024 |
Diep, I., & Widagdo, I. (2024). Use of 'number needed to treat' in optometry practice. Clinical and Experimental Optometry, 107(3), 349-350.
DOI |
| 2023 |
Andrade, A. Q., Widagdo, I., Lim, R., Kelly, T. L., Parfitt, G., Pratt, N., . . . Roughead, E. E. (2023). Correlation of frailty assessment metrics in one-year follow-up of aged care residents: a sub-study of a randomised controlled trial. Aging Clinical and Experimental Research, 35(10), 2081-2087.
DOI Scopus1 WoS1 Europe PMC1 |
| 2023 |
Kalisch Ellett, L. M., Dorj, G., Andrade, A. Q., Bilton, R. L., Rowett, D., Whitehouse, J., . . . Roughead, E. E. (2023). Prevalence and preventability of adverse medicine events in a sample of Australian aged-care residents: a secondary analysis of data from the ReMInDAR trial. Drug Safety, 46(5), 493-500.
DOI Scopus6 WoS4 Europe PMC4 |
| 2023 |
Dorj, G., Nair, N. P., Bereznicki, L., Kelly, T. L., Pratt, N., Kalisch-Ellett, L., . . . Roughead, E. (2023). Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial (Drugs & Aging, (2023), 40, 1, (49-58), 10.1007/s40266-022-00983-6). Drugs and Aging, 40(1), 89.
DOI |
| 2023 |
Dorj, G., Nair, N. P., Bereznicki, L., Thu Kelly, L., Pratt, N., Kalisch Ellet, L., . . . Roughead, E. (2023). Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial. Drugs & Aging, 40(1), 49-58.
DOI Scopus8 WoS8 Europe PMC7 |
| 2022 |
Dorj, G., Lim, R., Ellett, L. K., Kelly, T. L., Andrade, A., Widagdo, I., . . . Roughead, E. (2022). Medicine-related problems: a recurrent issue among residents living in nursing homes. Frontiers In Pharmacology, 13, 1-9.
DOI Scopus1 WoS2 Europe PMC1 |
| 2019 |
Lim, R., Kalisch Ellett, L. M., Widagdo, I. S., Pratt, N. L., & Roughead, E. E. (2019). Analysis of anticholinergic and sedative medicine effects on physical function, cognitive function, appetite and frailty: A cross-sectional study in Australia. BMJ Open, 9(9), 9 pages.
DOI Scopus35 WoS31 Europe PMC27 |
| 2018 |
Widagdo, I. S., Pratt, N. L., & Roughead, E. E. (2018). The association between frailty and medicines use over time: an analysis using the Australian Longitudinal Study on Ageing population. Journal of Pharmacy Practice and Research, 48(5), 405-415.
DOI |
| 2016 |
Widagdo, I. S., Pratt, N., Russell, M., & Roughead, E. E. (2016). Construct validity of four frailty measures in an older Australian population: a Rasch analysis. Journal of frailty & aging, 5(2), 78-81.
DOI Scopus17 WoS16 Europe PMC16 |
| 2015 |
Widagdo, I. S., Pratt, N., Russell, M., & Roughead, E. E. (2015). Predictive performance of four frailty measures in an older Australian population. Age and Ageing, 44(6), 967-972.
DOI Scopus36 WoS37 Europe PMC31 |
| 2015 |
Widagdo, I., Pratt, N., Russell, M., & Roughead, E. (2015). How common is frailty in older Australians?. Australasian Journal on Ageing, 34(4), 247-251.
DOI Scopus16 WoS13 Europe PMC12 |
| 2011 |
Widagdo, I. S., Nyfort Hansen, K., & Kowalski, S. R. (2011). Prevalence of potentially inappropriate medication use in elderly hospitalised patients. Journal of pharmacy practice and research, 41(2), 122-125.
DOI Scopus7 |
